Century Therapeutics
IPSC
70 hedge funds and large institutions have $14.1M invested in Century Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 29 reducing their positions, and 8 closing their positions.
3% less funds holding
Funds holding: 72 → 70 (-2)
8.45% less ownership
Funds ownership: 42.81% → 34.36% (-8.4%)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
45% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
62% less capital invested
Capital invested by funds: $36.8M → $14.1M (-$22.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$107K |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$65.3K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.7K |
| 4 |
Goldman Sachs
New York
|
+$28.6K |
| 5 |
Two Sigma Advisers
New York
|
+$19.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.62M |
| 2 |
CC
Casdin Capital
New York
|
-$1.49M |
| 3 |
VA
VR Adviser
New York
|
-$1.1M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$418K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$384K |
IPSC Hedge Fund Activity: Q1 2025 in Review
70 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q1 2025, worth a combined $14.1M — down 62% from $36.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IPSC and 6 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 16 added.
The largest buyer was Acadian Asset Management, adding an estimated $107K. The largest seller was Millennium Management, exiting entirely with an estimated $1.62M sold.
- 70 institutional investors held Century Therapeutics (IPSC) as of Q1 2025, down from 72 in Q4 2024.
- Funds reported $14.1M of Century Therapeutics stock for Q1 2025, down 62% quarter-over-quarter.
- 6 funds opened new Century Therapeutics positions in Q1 2025 and 8 closed out, a net change of -2 holders.
- The largest Century Therapeutics buyer in Q1 2025 was Acadian Asset Management, an estimated $107K added.
- The largest Century Therapeutics seller in Q1 2025 was Millennium Management, an estimated $1.62M sold.
Based on aggregated 13F filings for Q1 2025.